Abstract
Background
The first successful renal transplant was carried out more than five decades ago between identical twins. At these early days, acute rejection was the limiting factor.
Discussion
Due to tremendous progress in immunosuppressive therapy and surgical technique, today, renal transplantation is the gold standard therapy for patients with end-stage renal disease. In fact, in comparison with chronic hemodialysis, renal transplantation offers an increase in quality of life while reducing comorbidities associated with dialysis treatment.
Results
Despite numerous beneficial achievements, no further improvement regarding patient outcome can be observed over the last two decades. Graft survival rates remain unchanged. The leading causes for graft loss are chronic allograft nephropathy and death with functioning graft. This might be related to a constant increase of the proportion of donors presenting extended donor criteria as well as a more liberal acceptance of candidates for a renal transplant.
Conclusion
In the near future, one has to focus more closely on the posttransplant patient care to minimize factors associated with chronic allograft damage. These include post-transplant diabetes, hyperlipidemia, high blood pressure, cytomegalovirus infection, etc.
Similar content being viewed by others
Notes
Presented by H. Ekberg et al. at the “World Transplant Congress 2006”, 22.07.–27.07.2006, Boston, USA, Abstract number 49.
Presented by H. Ekberg et al. at the “World Transplant Congress 2006”, 22.07. – 27.07.2006, Boston, USA, Abstract number 49.
References
Lück R, Schrem H, Neipp M, Nashan B, Klempnauer J (2003) Living kidney transplantation. A comparison of Scandinavian countries and Germany. Chirurg 74(6):523
Ratner LE, Ciseck LJ, Moore RG, Cigarroa FG, Kaufman HS, Kavoussi LR (1995) Laparoscopic live donor nephrectomy. Transplantation 60(9):1047
Jones KW, Peters TG, Walker GW (1999) Anterior-retroperitoneal living donor nephrectomy: technique and outcomes. Am Surg 65(3):197
Velidedeoglu E, Williams N, Brayman KL et al (2002) Comparison of open, laparoscopic, and hand-assisted approaches to live-donor nephrectomy. Transplantation 74(2):169
Yang SL, Harkaway R, Badosa F, Ginsberg P, Greenstein MA (2002) Minimal incision living donor nephrectomy: improvement in patient outcome. Urology 59(5):673
Perry KT, Freedland SJ, Hu JC et al (2003) Quality of life, pain and return to normal activities following laparoscopic donor nephrectomy versus open mini-incision donor nephrectomy. J Urol 169(6):2018
Greenstein MA, Harkaway R, Badosa F, Ginsberg P, Yang SL (2003) Minimal incision living donor nephrectomy compared to the hand-assisted laparoscopic living donor nephrectomy. World J Urol 20(6):356
Neipp M, Jackobs S, Becker T et al (2004) Living donor nephrectomy: flank incision versus anterior vertical mini-incision. Transplantation 78(9):1356
Jackobs S, Becker T, Luck R et al (2005) Quality of life following living donor nephrectomy comparing classical flank incision and anterior vertical mini-incision. World J Urol 23:343
Gregoir W, Schulman CC (1977) Extravesical antirefluxplasty. Urologe 16(3):124
Neipp M, Becker T, Jackobs S et al Nierentransplantation nach Lebendspende: Ergebnisse von Organen mit anatomischen Variationen. 14. Jahrestagung der Deutschen Transplantationsgesellschaft, Rostock, Germany: Transplantationsmedizin, 2005: 23
Neipp M, Jackobs S, Jaeger M et al (2006) Living kidney donors >60 years of age: is it acceptable for the donor and the recipient? Transpl Int 19(3):213
Qvist E, Narhi V, Apajasalo M et al (2004) Psychosocial adjustment and quality of life after renal transplantation in early childhood. Pediatr Transplant 8(2):120
Pape L, Ehrich JH, Zivicnjak M, Offner G (2005) Growth in children after kidney transplantation with living related donor graft or cadaveric graft. Lancet 366(9480):151
Offner G, Latta K, Hoyer PF (1991) CAPD in children with special aspects of renal transplantation. Contrib Nephrol 89:243
Latta K, Offner G, Brodehl J (1992) Continuous peritoneal dialysis in children. Adv Perit Dial 8:406
Neipp M, Offner G, Luck R et al (2002) Kidney transplant in children weighing less than 15 kg: donor selection and technical considerations. Transplantation 73(3):409
Becker T, Neipp M, Reichart B et al (2006) Paediatric kidney transplantation in small children– a single centre experience. Transpl Int 19(3):197
Pape L, Hoppe J, Becker T et al (2006) Superior long-term graft function and better growth of grafts in children receiving kidneys from paediatric compared with adult donors. Nephrol Dial Transplant 21(9):2596
Loirat C, Chalem Y, Golmard JL (2001) Organ allocation in pediatric transplantation in France. Pediatr Nephrol 16(12):964
Tyden G, Kumlien G, Genberg H, Sandberg J, Lundgren T, Fehrman I (2005) ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab. Am J Transplant 5(1):145
Ahlenstiel T, Offner G, Strehlau J et al (2006) ABO-incompatible kidney transplantation of an 8-yr-old girl with donor/recipient-constellation A1B/B. Xenotransplantation 13(2):141
Radermacher J, Mengel M, Ellis S et al (2003) The renal arterial resistance index and renal allograft survival. N Engl J Med 349(2):115
Mengel M, Gwinner W, Schwarz A et al (2007) Infiltrates in protocol biopsies from renal allografts. Am J Transplant 7(2):356
Schwarz A, Mengel M, Gwinner W et al (2005) Risk factors for chronic allograft nephropathy after renal transplantation: a protocol biopsy study. Kidney Int 67(1):341
Rush DN, Jeffery JR, Gough J (1995) Sequential protocol biopsies in renal transplant patients. Clinico-pathological correlations using the Banff schema. Transplantation 59(4):511
Schlitt HJ, Hoffmann MW (2001) Reconstruction of necrotic kidney graft pelvis with a vascularized small bowel patch. Transpl Int 14(2):95
Mengel M, Chapman JR, Cosio FG et al (2007) Protocol Biopsies in Renal Transplantation: Insights into Patient Management and Pathogenesis. Am J Transplant 7:512–517
Hardinger KL, Schnitzler MA, Koch MJ et al (2006) Thymoglobulin induction is safe and effective in live-donor renal transplantation: a single center experience. Transplantation 81(9):1285
Qiu J, Cai J, Terasaki PL Death with a functioning graft in kidney transplant recipients. Clin Transpl 2004:379–386
Schiel R, Heinrich S, Steiner T, Ott U, Stein G (2005) Post-transplant diabetes mellitus: risk factors, frequency of transplant rejections, and long-term prognosis. Clin Exp Nephrol 9(2):164
Joss N, Staatz CE, Thomson AH, Jardine AG (2007) Predictors of new onset diabetes after renal transplantation. Clin Transplant 21(1):136
Salvadori M, Bertoni E, Rosati A, Zanazzi M (2003) Post-transplant diabetes mellitus. J Nephrol 16(5):626
Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ (2003) Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 3(2):178
Eypasch E, Wood-Dauphinee S, Williams JI, Ure B, Neugebauer E, Troidl H (1993) The Gastrointestinal Quality of Life Index. A clinical index for measuring patient status in gastroenterologic surgery. Chirurg 64(4):264
Vitko S, Margreiter R, Weimar W et al (2005) Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients. Am J Transplant 5(10):2521
Birkeland SA, Lokkegaard H, Storm HH (2000) Cancer risk in patients on dialysis and after renal transplantation. Lancet 355(9218):1886
Penn I (1997) Evaluation of transplant candidates with pre-existing malignancies. Ann Transplant 2(4):14
Campistol JM, Gutierrez-Dalmau A, Torregrosa JV (2004) Conversion to sirolimus: a successful treatment for posttransplantation Kaposi’s sarcoma. Transplantation 77(5):760
Stallone G, Schena A, Infante B et al (2005) Sirolimus for Kaposi’s sarcoma in renal-transplant recipients. N Engl J Med 352(13):1317
Fischer A, Blanche S, Le Bidois J et al (1991) Anti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med 324(21):1451
Luan FL, Ding R, Sharma VK, Chon WJ, Lagman M, Suthanthiran M (2003) Rapamycin is an effective inhibitor of human renal cancer metastasis. Kidney Int 63(3):917
Guba M, Graeb C, Jauch KW, Geissler EK (2004) Pro- and anti-cancer effects of immunosuppressive agents used in organ transplantation. Transplantation 77(12):1777
Fujisawa M, Ichikawa Y, Yoshiya K et al (2000) Assessment of health-related quality of life in renal transplant and hemodialysis patients using the SF-36 health survey. Urology 56(2):201
Neipp M, Karavul B, Jackobs S et al (2006) Quality of life in adult transplant recipients more than 15 years after kidney transplantation. Transplantation 81(12):1640
Bullinger M (2000) Erfassung der gesundheitsbezogenen Lebensqualität mit dem SF-36 Health Survey. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 43:190
Laupacis A, Pus N, Muirhead N, Wong C, Ferguson B, Keown P (1993) Disease-specific questionnaire for patients with a renal transplant. Nephron 64(2):226
Hagenmeyer EG, Haussler B, Hempel E et al (2004) Resource use and treatment costs after kidney transplantation: impact of demographic factors, comorbidities, and complications. Transplantation 77(10):1545
Shaffer D, Langone A, Nylander WA, Goral S, Kizilisik AT, Helderman JH (2003) A pilot protocol of a calcineurin-inhibitor free regimen for kidney transplant recipients of marginal donor kidneys or with delayed graft function. Clin Transplant 17(Suppl 9):31
Segoloni GP, Messina M, Squiccimarro G et al (2005) Preferential allocation of marginal kidney allografts to elderly recipients combined with modified immunosuppression gives good results. Transplantation 80(7):953
Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D (2000) Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 342(9):605
Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B (2004) Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 4(3):378
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Neipp, M., Jackobs, S. & Klempnauer, J. Renal transplantation today. Langenbecks Arch Surg 394, 1–16 (2009). https://doi.org/10.1007/s00423-008-0335-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00423-008-0335-1